🔴 Eupraxia Pharmaceuticals is trading 5.94% down today amid a 1.04% Nasdaq Composite decline

Eupraxia Pharmaceuticals is trading 5.94% lower at $8.07, with the decline appearing mainly aligned with weaker broader-market sentiment during the September 23, 2026 session.

• The Nasdaq Composite fell 1.04%.
• No fresh company-specific announcement or analyst action was identified for September 23; available analyst-action listings show no EPRX action today.
• The latest notable company news was its September 8 Nasdaq Global Select Market transfer.